BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND MYC, c-Myc, 4609, ENSG00000136997
372 results:

  • 1. Primary manifestation of HIV-related Burkitt lymphoma in the oral and maxillofacial regions.
    Silva Filho NJD; Cardoso DM; Kayahara GM; Xavier-Júnior JCC; Cortopassi GM; Fonseca FP; Miyahara GI; Bernabé DG; Valente VB
    J Am Dent Assoc; 2024 Apr; 155(4):344-348. PubMed ID: 38244019
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
    Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
    [No Abstract]    [Full Text] [Related]  

  • 3. hodgkin lymphoma: A disease shaped by the tumor micro- and macroenvironment.
    Masel R; Roche ME; Martinez-Outschoorn U
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cytogenetics in the management of mature B-cell non-hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH).
    Lefebvre C; Veronese L; Nadal N; Gaillard JB; Penther D; Daudignon A; Chauzeix J; Nguyen-Khac F; Chapiro E
    Curr Res Transl Med; 2023; 71(4):103425. PubMed ID: 38016420
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant hodgkin lymphoma Suggests an Intact Immune Surveillance Program.
    Weiss J; Gibbons K; Ehyaee V; Perez-Silos V; Zevallos A; Maienschein-Cline M; Brister E; Sverdlov M; Shah E; Balakrishna J; Symes E; Frederiksen JK; Gann PH; Post R; Lopez-Hisijos N; Reneau J; Venkataraman G; Bailey N; Brown NA; Xu ML; Wilcox RA; Inamdar K; Murga-Zamalloa C
    Am J Pathol; 2024 Jan; 194(1):165-178. PubMed ID: 37923249
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.
    Leopizzi M; Mundo L; Messina E; Campolo F; Lazzi S; Angeloni A; Marchese C; Leoncini L; Giordano C; Slack F; Trivedi P; Anastasiadou E
    Blood; 2024 Feb; 143(5):429-443. PubMed ID: 37847858
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proliferation-promoting roles of linear and circular PVT1 are independent of their ability to bind miRNAs in B-cell lymphoma.
    Zhao X; van den Berg A; Winkle M; Koerts J; Seitz A; de Jong D; Rutgers B; van der Sluis T; Bakker E; Kluiver J
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126744. PubMed ID: 37689284
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Aggressive B-cell non-hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
    Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BET inhibitors induce NF-κB and E2F downregulation in hodgkin and Reed-Sternberg cells.
    Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
    Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. myc rearrangement and concurrent high protein expression of C-myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
    Wang X; He J; He H; Shuai Y; Wang L; Li Y; Huang Y; Yu K; Zhao M; Xie T; Li D
    Ann Diagn Pathol; 2023 Oct; 66():152165. PubMed ID: 37348414
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
    Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
    Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Investigating In Situ Expression of c-myc and Candidate Ubiquitin-Specific Proteases in DLBCL and Assessment for Peptidyl Disruptor Molecule against c-myc-USP37 Complex.
    Kamran DES; Hussain M; Mirza T
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985413
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
    Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
    Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Burkitt lymphoma.
    López C; Burkhardt B; Chan JKC; Leoncini L; Mbulaiteye SM; Ogwang MD; Orem J; Rochford R; Roschewski M; Siebert R
    Nat Rev Dis Primers; 2022 Dec; 8(1):78. PubMed ID: 36522349
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients.
    Berg HE; Peterson JF; Lee HE; McPhail ED
    Hum Pathol; 2023 Jan; 131():108-115. PubMed ID: 36470475
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
    Ten Hacken E; Sewastianik T; Yin S; Hoffmann GB; Gruber M; Clement K; Penter L; Redd RA; Ruthen N; Hergalant S; Sholokhova A; Fell G; Parry EM; Broséus J; Guieze R; Lucas F; Hernández-Sánchez M; Baranowski K; Southard J; Joyal H; Billington L; Regis FFD; Witten E; Uduman M; Knisbacher BA; Li S; Lyu H; Vaisitti T; Deaglio S; Inghirami G; Feugier P; Stilgenbauer S; Tausch E; Davids MS; Getz G; Livak KJ; Bozic I; Neuberg DS; Carrasco RD; Wu CJ
    Blood Cancer Discov; 2023 Mar; 4(2):150-169. PubMed ID: 36468984
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and hodgkin lymphoma.
    Wei W; Song Z; Chiba M; Wu W; Jeong S; Zhang JP; Kadin ME; Nakagawa M; Yang Y
    Leukemia; 2023 Feb; 37(2):396-407. PubMed ID: 36456744
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Richter transformation in Chronic Lymphocytic Leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
    Li L; Nie L; Jordan A; Cai Q; Liu Y; Li Y; Che Y; Vargas J; Chen Z; Leeming A; Wang W; Yao Y; Wang M; Jiang VC
    Haematologica; 2023 Jun; 108(6):1616-1627. PubMed ID: 36420799
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Two cases of follicular lymphoma with myc gene abnormalities that presented with bone marrow necrosis.
    Miyazawa Y; Takei H; Kobayashi N; Akashi N; Sairenji Y; Sugisaki M; Naito C; Ishikawa T; Shimizu H; Ishizaki T; Yokohama A; Tsukamoto N; Yoshida Y; Matsumura N; Takayama Y; Handa H
    J Clin Exp Hematop; 2022 Dec; 62(4):208-216. PubMed ID: 36261333
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.